1% Lymphazurin vs 10% fluorescein for sentinel node mapping in colorectal tumours (Structured abstract)      
A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group (Structured abstract)      
A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease (Structured abstract)      
A 10% ready-to-use intravenous human immunoglobulin offers potential economic advantages over a lyophilized product in the treatment of primary immunodeficiency (Provisional abstract)      
The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS (Provisional abstract)      
17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: a cost-effectiveness analysis (Structured abstract)      
1818F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management (Provisional abstract)      
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography accuracy in the staging of non-small cell lung cancer: review and cost-effectiveness (Provisional abstract)      New 
18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation (Structured abstract)      
18FDG-PET/CT cost-effectiveness compared to CT at the end of treatment in pediatric Hodgkin's lymphoma patients (Provisional abstract)      New 
The 2-year cost-effectiveness of 3 options to treat lumbar spinal stenosis patients (Structured abstract)      
The 2-year costs and effects of a public health nursing case management intervention on mood-disordered single parents on social assistance (Structured abstract)      
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for er-positive, nodenegative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use (Provisional abstract)      
The 23-valent pneumococcal polysaccharide vaccine. Part II: a cost-effectiveness analysis for invasive disease in the elderly in England and Wales (Structured abstract)      
A 3-year follow-up of pre-emptive vs deferred treatment of cytomegalovirus disease in renal transplantation (Structured abstract)      
A 3-year prospective randomized controlled clinical trial of group care in type 1 diabetes (Structured abstract)      
A 36-month study on the cost/utility of add-on omalizumab in persistent difficult-to-treat atopic asthma in Italy (Provisional abstract)      
4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity (Provisional abstract)      
440 consecutive immediate, implant-based, single-surgeon breast reconstructions in 281 patients: a comparison of early outcomes and costs between SurgiMend fetal bovine and AlloDerm human cadaveric acellular dermal matrices (Structured abstract)      
A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study (Structured abstract)      
5-year cost/benefit analysis of revision of failed unicompartmental knee replacements (UKRs); not "just" a primary total knee replacement (TKR) (Provisional abstract)      
A 5-year follow-up evaluation of the health and economic consequences of an early cognitive behavioral intervention for back pain: a randomized, controlled trial (Structured abstract)      
A 6-year antifungal stewardship programme in a teaching hospital (Provisional abstract)      
A 6-year comparative economic evaluation of healthcare costs and mortality rates of Dutch patients from conventional and CAM GPs (Provisional abstract)      New